According to the BBC GlaxoSmithKline, the largest British drugs firm which also has a significant presence back in the old home town of Philadelphia, withheld evidence from regulators relating to teen suicide during the approval process for its anti-depressant Seroxat. The BBC reported their findings on the programme Panorama. Their evidence included statements from former employees and emails which showed that the company was aware that there was little or no evidence that the drug was effective for use in the adolescent population but continued to promote it for use.
GSK, as could be expected, denies the charges.
GSK, as could be expected, denies the charges.
1 comment:
You can read more about the dangers of Seroxat on my blog at http://fiddaman.blogspot.com/. You will see through the various articles posted on there that the MHRA have known for some considerable time that Seroxat is not only dangerous in the children population but also the adult poulation too
Bob Fiddaman
Post a Comment